BRPI0716391A2 - método de previsão de metástase distante de câncer de mama primário nódulo linfático-negativo usando análise de expressão gênica de via biloógica - Google Patents
método de previsão de metástase distante de câncer de mama primário nódulo linfático-negativo usando análise de expressão gênica de via biloógicaInfo
- Publication number
- BRPI0716391A2 BRPI0716391A2 BRPI0716391A BRPI0716391A BRPI0716391A2 BR PI0716391 A2 BRPI0716391 A2 BR PI0716391A2 BR PI0716391 A BRPI0716391 A BR PI0716391A BR PI0716391 A BRPI0716391 A BR PI0716391A BR PI0716391 A2 BRPI0716391 A2 BR PI0716391A2
- Authority
- BR
- Brazil
- Prior art keywords
- bile
- logical
- gene expression
- breast cancer
- prediction method
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84221206P | 2006-09-05 | 2006-09-05 | |
PCT/US2007/077593 WO2008030845A2 (en) | 2006-09-05 | 2007-09-05 | Methods of predicting distant metastasis of lymph node-negative primary breast cancer using biological pathway gene expression analysis |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0716391A2 true BRPI0716391A2 (pt) | 2017-01-31 |
Family
ID=39157990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0716391A BRPI0716391A2 (pt) | 2006-09-05 | 2007-09-05 | método de previsão de metástase distante de câncer de mama primário nódulo linfático-negativo usando análise de expressão gênica de via biloógica |
Country Status (8)
Country | Link |
---|---|
US (1) | US20080182246A1 (pt) |
EP (1) | EP2061905A4 (pt) |
JP (1) | JP2010502227A (pt) |
CN (1) | CN101573453A (pt) |
BR (1) | BRPI0716391A2 (pt) |
CA (1) | CA2662501A1 (pt) |
MX (1) | MX2009002535A (pt) |
WO (1) | WO2008030845A2 (pt) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9863952B2 (en) * | 2008-03-31 | 2018-01-09 | Council Of Scientific & Industrial Research | Method for the diagnosis of higher- and lower-grade astrocytoma using biomarkers and diagnostic kit thereof |
EP2108705A1 (en) * | 2008-04-08 | 2009-10-14 | Universität Duisburg-Essen | Method for analysing the epigenetic status of the HtrA 1 gene in a biological sample |
GB0808668D0 (en) * | 2008-05-13 | 2008-06-18 | Univ Aberdeen | Materials and methods relating to a G-protein coupled receptor |
EP2499160B1 (en) | 2009-11-12 | 2016-10-05 | Alper Biotech, Llc | Monoclonal antibodies against gmf-beta antigens, and uses therefor |
RU2012148125A (ru) * | 2010-04-13 | 2014-05-20 | Дзе Трастиз Оф Коламбия Юниверсити Ин Дзе Сити Оф Нью Йорк | Биомаркеры на основе мультиракового ассоциированного с инвазией механизма |
EP2603796B1 (en) | 2010-08-13 | 2016-05-25 | Arizona Board of Regents, a body corporate acting on behalf of Arizona State University | Biomarkers for the early detection of breast cancer |
EP2463658A1 (en) * | 2010-12-13 | 2012-06-13 | Université de Liège | Biomarkers, uses of biomarkers and a method of identifying biomarkers |
WO2012154957A2 (en) * | 2011-05-11 | 2012-11-15 | Alper Biotech, Llp | Diagnosis and prognosis of triple negative breast and ovarian cancer |
RU2544094C2 (ru) * | 2012-12-29 | 2015-03-10 | Общество с ограниченной ответственностью "Митрель-Люмитек" | Способ интраоперационной визуализации патологических очагов |
KR101672531B1 (ko) * | 2013-04-18 | 2016-11-17 | 주식회사 젠큐릭스 | 조기 유방암 예후 예측 진단용 유전자 마커 및 이의 용도 |
CA2915823A1 (en) * | 2013-06-19 | 2014-12-24 | Memorial Sloan-Kettering Cancer Center | Methods and compositions for the diagnosis, prognosis and treatment of brain metastasis |
TWI615472B (zh) * | 2013-09-18 | 2018-02-21 | Nat Defense Medical Center | 預測乳癌復發之基因標記及方法 |
MX2016011612A (es) * | 2014-03-11 | 2016-12-12 | The Council Of The Queensland Inst Of Medical Res | Determinacion de agresividad, pronostico y responsividad del cancer al tratamiento. |
US20160026759A1 (en) * | 2014-07-22 | 2016-01-28 | Yourgene Bioscience | Detecting Chromosomal Aneuploidy |
CN113899902A (zh) * | 2020-06-22 | 2022-01-07 | 上海科技大学 | 一种酪氨酸磷酸酶底物鉴定方法 |
CN113151355A (zh) * | 2021-04-01 | 2021-07-23 | 吉林省农业科学院 | 鸡strn3基因3’utr的双荧光素酶报告基因载体及其构建方法与应用 |
CN114034866A (zh) * | 2021-11-29 | 2022-02-11 | 湖州市中心医院 | 乳腺癌诊断标志物及其应用 |
CN114452391B (zh) * | 2022-01-28 | 2023-08-25 | 深圳市泰尔康生物医药科技有限公司 | Cdk16作为靶标在制备用于治疗三阴性乳腺癌的药物中的应用 |
-
2007
- 2007-09-05 EP EP07841857A patent/EP2061905A4/en not_active Ceased
- 2007-09-05 WO PCT/US2007/077593 patent/WO2008030845A2/en active Application Filing
- 2007-09-05 CN CNA2007800410540A patent/CN101573453A/zh active Pending
- 2007-09-05 US US11/850,160 patent/US20080182246A1/en not_active Abandoned
- 2007-09-05 MX MX2009002535A patent/MX2009002535A/es not_active Application Discontinuation
- 2007-09-05 JP JP2009527533A patent/JP2010502227A/ja not_active Abandoned
- 2007-09-05 CA CA002662501A patent/CA2662501A1/en not_active Abandoned
- 2007-09-05 BR BRPI0716391A patent/BRPI0716391A2/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MX2009002535A (es) | 2009-03-20 |
US20080182246A1 (en) | 2008-07-31 |
CA2662501A1 (en) | 2008-03-13 |
WO2008030845A2 (en) | 2008-03-13 |
CN101573453A (zh) | 2009-11-04 |
WO2008030845A3 (en) | 2008-11-27 |
EP2061905A4 (en) | 2009-09-30 |
EP2061905A2 (en) | 2009-05-27 |
WO2008030845A8 (en) | 2009-11-05 |
JP2010502227A (ja) | 2010-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0716391A2 (pt) | método de previsão de metástase distante de câncer de mama primário nódulo linfático-negativo usando análise de expressão gênica de via biloógica | |
CY2020039I2 (el) | Νεα anti-cd38 αντισωματα για τη θεραπευτικη αγωγη καρκινου | |
IL276488A (en) | A method for predicting the prognosis of breast cancer | |
DK2115472T3 (da) | Cancerbiomarkører | |
ZA200905897B (en) | Method for predicting the occurrence of metastasis in breast cancer patients | |
BRPI0919705A2 (pt) | método de comtrole geoquímico de fluidos de fraturamento | |
NZ606725A (en) | Methods for predicting anti-cancer response | |
BRPI1006075A2 (pt) | biomarcadores de cancer | |
DK3101141T3 (da) | Fremgangsmåde til methyleringsanalyse | |
BRPI0809989A2 (pt) | antígeno associado com a neovasculatura de metástases tumorais | |
TN2013000464A1 (en) | Biomarkers for hedgehog inhibitor therapy | |
EP2686450A4 (en) | BIOLOGICAL MARKERS FOR PREDICTING THE RECIPIENT OF COLORECTAL CANCER METASTASIS | |
HK1165836A1 (en) | Method for detecting metastasis of gi cancer | |
DK3176270T3 (da) | Forudsigelse af melanomcancerprognose | |
EP2281903A4 (en) | CANCER MARKER, METHOD FOR EVALUATING CANCER USING THE CANCER MARKER AND ASSESSING THE VALUE | |
IL205347A0 (en) | Process for predicting the prognosis of squamous cell lung cancer | |
EP2488666A4 (en) | BIOMARKERS AND METHODS OF IDENTIFICATION FOR EARLY DETECTION AND PREDICTION OF BREAST CANCER RECOVERY USING NMR (NUCLEAR MAGNETIC RESONANCE) | |
EP2279416A4 (en) | METHOD FOR PREDICTING THE RISK OF METASTASES | |
HK1144556A1 (en) | Inhibition of tumor metastasis by anti-neuropilin antibodies | |
EP2354790A4 (en) | METHOD FOR DETERMINING CANCER OF PROSTATE | |
EP2220506A4 (en) | BIOMARKERS FOR THE DETECTION OF OVARIAL CARCINOMA IN EASTER STAGE | |
EP2707721A4 (en) | BIOMARKERS PREDICTIVE FOR PROSTATE CANCER | |
IT1394416B1 (it) | Apparato per la realizzazione di pannelli tamburati. | |
EP2210099A4 (en) | BIOMARKER FOR OVARIAL CARCINOMA | |
IL210745A0 (en) | Methods of predicting cancer lethality using replikin counts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |